Nadia Permalloo

Nadia is Head of Screening Quality Assurance Development (Clinical) for the Screening Quality Assurance Service (National team)
Nadia Permalloo has worked in screening since 1998. She has worked in screening programmes at local, regional and national levels and is a registered nurse and midwife.

Nadia currently works nationally in quality assurance for the PHE Screening Quality Assurance Service. She cares that women and babies have high quality care and that we should be continually striving to improve what we do by supporting and developing staff delivering screening programmes.

Workshops have positive impact on antenatal screening data

The national antenatal screening team travelled across the country to deliver data workshops to give screening providers guidance on the submission of complete and accurate screening standards and key performance indicator data.

New quality assurance e-learning screening modules

Nadia Permalloo, 20 August 2018 - NHS Abdominal Aortic Aneurysm Screening Programme, NHS Fetal Anomaly Screening Programme, NHS Infectious Diseases in Pregnancy Screening Programme, NHS Newborn and Infant Physical Examination, NHS Newborn Blood Spot Screening Programme, NHS Newborn Hearing Screening Programme, NHS Sickle Cell and Thalassaemia Screening Programme, Screening Quality Assurance Service

We've launched 3 e-learning modules aimed at our screening quality assurance service staff and the professional and clinical advisors who provide specialist expertise.

Improving quality in Down’s, Edwards’ and Patau’s screening laboratories

Nadia Permalloo and David Wright, 7 February 2018 - NHS Fetal Anomaly Screening Programme, Screening Quality Assurance Service

Shared learning in this blog post is specifically aimed at laboratories that provide Down’s, Edwards’ and Patau’s screening.

Sharing best practice in newborn hearing screening to ensure early assessment of babies

Sonia Segalini and Nadia Permalloo, 19 January 2018 - NHS Newborn Hearing Screening Programme

Report highlights how best performing newborn hearing screening sites ensure early assessment of screen-positive babies in audiology.

We’ve published first annual fetal anomaly screening data report

Nadia Permalloo and Annette McHugh, 10 November 2017 - NHS Fetal Anomaly Screening Programme

We are pleased to publish the first annual data report for the NHS Fetal Anomaly Screening Programme (FASP).

We have published the first annual data report for the NHS Fetal Anomaly Screening Programme (FASP). It covers the period 1 April 2015 to 31 March 2016 and provides feedback on completeness of data submission and performance against the national standards.

Does age matter when thinking of NHS newborn screening programmes?

Nadia Permalloo, 4 September 2017 - NHS Newborn and Infant Physical Examination, NHS Newborn Blood Spot Screening Programme, NHS Newborn Hearing Screening Programme

We have recently updated and published a one page summary for healthcare professionals explaining which newborn screening tests can be offered at different ages if any of these were initially missed.

Guidance on supporting agency sonographers for fetal anomaly screening

Nadia Permalloo, 6 April 2017 - NHS Fetal Anomaly Screening Programme

If you work in ultrasound or radiology you will be well aware there’s a national shortage of trained staff. Many ultrasound departments rely on agency sonographers.

Submitting antenatal screening coverage KPI data just got easier

Nadia Permalloo, 4 April 2017 - General information, NHS Fetal Anomaly Screening Programme, NHS Infectious Diseases in Pregnancy Screening Programme, NHS Sickle Cell and Thalassaemia Screening Programme

We use key performance indicator (KPI) data to measure how the NHS screening programmes are performing.

Sickle cell and thalassaemia screening: fathers matter

Nadia Permalloo, 30 March 2017 - NHS Sickle Cell and Thalassaemia Screening Programme

We offer screening for sickle cell and thalassaemia (SCT) to all pregnant women. We also offer to screen the baby’s biological father if the mother is found to be a carrier of or have a sickle cell or thalassaemia condition.

Getting out and about to make sense of antenatal screening data collection

Nadia Permalloo and Sharon Webb, 21 March 2017 - NHS Fetal Anomaly Screening Programme, NHS Infectious Diseases in Pregnancy Screening Programme, NHS Sickle Cell and Thalassaemia Screening Programme

Our 3 antenatal screening programmes have joined forces with the national Screening Quality Assurance Service (SQAS) team to hold 8 regional workshops during 2017.

Nadia Permalloo

Workshops have positive impact on antenatal screening data

New quality assurance e-learning screening modules

Improving quality in Down’s, Edwards’ and Patau’s screening laboratories

Sharing best practice in newborn hearing screening to ensure early assessment of babies

We’ve published first annual fetal anomaly screening data report

Does age matter when thinking of NHS newborn screening programmes?

Guidance on supporting agency sonographers for fetal anomaly screening

Submitting antenatal screening coverage KPI data just got easier

Sickle cell and thalassaemia screening: fathers matter

Getting out and about to make sense of antenatal screening data collection

The PHE Screening team

Categories

Useful links

Comments and moderation

Recent posts

Follow us on social media

Nadia Permalloo

Related content and links

The PHE Screening team

Categories

Useful links

Blog tags

Comments and moderation

Recent posts

Follow us on social media